Literature DB >> 30412185

An avatar for precision cancer therapy.

Shumei Kato1, Razelle Kurzrock1.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30412185     DOI: 10.1038/nbt.4293

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  11 in total

1.  Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Authors:  D J Slamon; B Leyland-Jones; S Shak; H Fuchs; V Paton; A Bajamonde; T Fleming; W Eiermann; J Wolter; M Pegram; J Baselga; L Norton
Journal:  N Engl J Med       Date:  2001-03-15       Impact factor: 91.245

2.  High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response.

Authors:  Hui Gao; Joshua M Korn; Stéphane Ferretti; John E Monahan; Youzhen Wang; Mallika Singh; Chao Zhang; Christian Schnell; Guizhi Yang; Yun Zhang; O Alejandro Balbin; Stéphanie Barbe; Hongbo Cai; Fergal Casey; Susmita Chatterjee; Derek Y Chiang; Shannon Chuai; Shawn M Cogan; Scott D Collins; Ernesta Dammassa; Nicolas Ebel; Millicent Embry; John Green; Audrey Kauffmann; Colleen Kowal; Rebecca J Leary; Joseph Lehar; Ying Liang; Alice Loo; Edward Lorenzana; E Robert McDonald; Margaret E McLaughlin; Jason Merkin; Ronald Meyer; Tara L Naylor; Montesa Patawaran; Anupama Reddy; Claudia Röelli; David A Ruddy; Fernando Salangsang; Francesca Santacroce; Angad P Singh; Yan Tang; Walter Tinetto; Sonja Tobler; Roberto Velazquez; Kavitha Venkatesan; Fabian Von Arx; Hui Qin Wang; Zongyao Wang; Marion Wiesmann; Daniel Wyss; Fiona Xu; Hans Bitter; Peter Atadja; Emma Lees; Francesco Hofmann; En Li; Nicholas Keen; Robert Cozens; Michael Rugaard Jensen; Nancy K Pryer; Juliet A Williams; William R Sellers
Journal:  Nat Med       Date:  2015-10-19       Impact factor: 53.440

3.  Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy.

Authors:  Jin-Ku Lee; Zhaoqi Liu; Jason K Sa; Sang Shin; Jiguang Wang; Mykola Bordyuh; Hee Jin Cho; Oliver Elliott; Timothy Chu; Seung Won Choi; Daniel I S Rosenbloom; In-Hee Lee; Yong Jae Shin; Hyun Ju Kang; Donggeon Kim; Sun Young Kim; Moon-Hee Sim; Jusun Kim; Taehyang Lee; Yun Jee Seo; Hyemi Shin; Mijeong Lee; Sung Heon Kim; Yong-Jun Kwon; Jeong-Woo Oh; Minsuk Song; Misuk Kim; Doo-Sik Kong; Jung Won Choi; Ho Jun Seol; Jung-Il Lee; Seung Tae Kim; Joon Oh Park; Kyoung-Mee Kim; Sang-Yong Song; Jeong-Won Lee; Hee-Cheol Kim; Jeong Eon Lee; Min Gew Choi; Sung Wook Seo; Young Mog Shim; Jae Ill Zo; Byong Chang Jeong; Yeup Yoon; Gyu Ha Ryu; Nayoung K D Kim; Joon Seol Bae; Woong-Yang Park; Jeongwu Lee; Roel G W Verhaak; Antonio Iavarone; Jeeyun Lee; Raul Rabadan; Do-Hyun Nam
Journal:  Nat Genet       Date:  2018-09-27       Impact factor: 38.330

4.  Assessing PIK3CA and PTEN in early-phase trials with PI3K/AKT/mTOR inhibitors.

Authors:  Filip Janku; David S Hong; Siqing Fu; Sarina A Piha-Paul; Aung Naing; Gerald S Falchook; Apostolia M Tsimberidou; Vanda M Stepanek; Stacy L Moulder; J Jack Lee; Rajyalakshmi Luthra; Ralph G Zinner; Russell R Broaddus; Jennifer J Wheler; Razelle Kurzrock
Journal:  Cell Rep       Date:  2014-01-16       Impact factor: 9.423

5.  Rosai-Dorfman Disease with Activating KRAS Mutation - Response to Cobimetinib.

Authors:  Eric Jacobsen; Vignesh Shanmugam; Jyothi Jagannathan
Journal:  N Engl J Med       Date:  2017-12-14       Impact factor: 91.245

6.  Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center Study.

Authors:  Jennifer J Wheler; Filip Janku; Aung Naing; Yali Li; Bettzy Stephen; Ralph Zinner; Vivek Subbiah; Siqing Fu; Daniel Karp; Gerald S Falchook; Apostolia M Tsimberidou; Sarina Piha-Paul; Roosevelt Anderson; Danxia Ke; Vincent Miller; Roman Yelensky; J Jack Lee; David S Hong; Razelle Kurzrock
Journal:  Cancer Res       Date:  2016-05-18       Impact factor: 12.701

7.  Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.

Authors:  Stephen G O'Brien; François Guilhot; Richard A Larson; Insa Gathmann; Michele Baccarani; Francisco Cervantes; Jan J Cornelissen; Thomas Fischer; Andreas Hochhaus; Timothy Hughes; Klaus Lechner; Johan L Nielsen; Philippe Rousselot; Josy Reiffers; Giuseppe Saglio; John Shepherd; Bengt Simonsson; Alois Gratwohl; John M Goldman; Hagop Kantarjian; Kerry Taylor; Gregor Verhoef; Ann E Bolton; Renaud Capdeville; Brian J Druker
Journal:  N Engl J Med       Date:  2003-03-13       Impact factor: 91.245

8.  Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.

Authors:  Jean-Charles Soria; Yuichiro Ohe; Johan Vansteenkiste; Thanyanan Reungwetwattana; Busyamas Chewaskulyong; Ki Hyeong Lee; Arunee Dechaphunkul; Fumio Imamura; Naoyuki Nogami; Takayasu Kurata; Isamu Okamoto; Caicun Zhou; Byoung Chul Cho; Ying Cheng; Eun Kyung Cho; Pei Jye Voon; David Planchard; Wu-Chou Su; Jhanelle E Gray; Siow-Ming Lee; Rachel Hodge; Marcelo Marotti; Yuri Rukazenkov; Suresh S Ramalingam
Journal:  N Engl J Med       Date:  2017-11-18       Impact factor: 91.245

9.  Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.

Authors:  Georgios Vlachogiannis; Somaieh Hedayat; Alexandra Vatsiou; Yann Jamin; Javier Fernández-Mateos; Khurum Khan; Andrea Lampis; Katherine Eason; Ian Huntingford; Rosemary Burke; Mihaela Rata; Dow-Mu Koh; Nina Tunariu; David Collins; Sanna Hulkki-Wilson; Chanthirika Ragulan; Inmaculada Spiteri; Sing Yu Moorcraft; Ian Chau; Sheela Rao; David Watkins; Nicos Fotiadis; Maria Bali; Mahnaz Darvish-Damavandi; Hazel Lote; Zakaria Eltahir; Elizabeth C Smyth; Ruwaida Begum; Paul A Clarke; Jens C Hahne; Mitchell Dowsett; Johann de Bono; Paul Workman; Anguraj Sadanandam; Matteo Fassan; Owen J Sansom; Suzanne Eccles; Naureen Starling; Chiara Braconi; Andrea Sottoriva; Simon P Robinson; David Cunningham; Nicola Valeri
Journal:  Science       Date:  2018-02-23       Impact factor: 47.728

10.  Primary Patient-Derived Cancer Cells and Their Potential for Personalized Cancer Patient Care.

Authors:  David P Kodack; Anna F Farago; Anahita Dastur; Matthew A Held; Leila Dardaei; Luc Friboulet; Friedrich von Flotow; Leah J Damon; Dana Lee; Melissa Parks; Richard Dicecca; Max Greenberg; Krystina E Kattermann; Amanda K Riley; Florian J Fintelmann; Coleen Rizzo; Zofia Piotrowska; Alice T Shaw; Justin F Gainor; Lecia V Sequist; Matthew J Niederst; Jeffrey A Engelman; Cyril H Benes
Journal:  Cell Rep       Date:  2017-12-12       Impact factor: 9.423

View more
  3 in total

Review 1.  Advances of Patient-Derived Organoids in Personalized Radiotherapy.

Authors:  Yuenan Wang; Ye Li; Zonghai Sheng; Weiwei Deng; Hongyan Yuan; Shubin Wang; Yajie Liu
Journal:  Front Oncol       Date:  2022-04-29       Impact factor: 5.738

Review 2.  The paradox of cancer genes in non-malignant conditions: implications for precision medicine.

Authors:  Jacob J Adashek; Shumei Kato; Scott M Lippman; Razelle Kurzrock
Journal:  Genome Med       Date:  2020-02-17       Impact factor: 11.117

Review 3.  State of the Art Review on Genetics and Precision Medicine in Arrhythmogenic Cardiomyopathy.

Authors:  Viraj Patel; Babken Asatryan; Bhurint Siripanthong; Patricia B Munroe; Anjali Tiku-Owens; Luis R Lopes; Mohammed Y Khanji; Alexandros Protonotarios; Pasquale Santangeli; Daniele Muser; Francis E Marchlinski; Peter A Brady; C Anwar A Chahal
Journal:  Int J Mol Sci       Date:  2020-09-10       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.